Videos | HIMSS

ITN Editor Dave Fornell takes a tour of some of the most innovative new technology that was displayed on the expo floor ...

Home March 10, 2017
Home
News | Ventricular Assist Devices (VAD)

Metro Detroit cardiologists from five health systems have joined together to increase residents’ survival rate from heart attacks.

Home March 09, 2017
Home
News | Cardiac Imaging

To ensure imaging systems are operating safely and at optimum performance with appropriate and preventative maintenance, Toshiba Medical has introduced a customized PM Only Service Agreement to customers. The PM Only Service Agreement allows providers to fulfill and document that they are compliant with the Centers for Medicare & Medicaid (CMS) Directive and The Joint Commission’s (TJC) guidelines of ensuring all imaging equipment meets manufacturers’ specifications.

Home March 09, 2017
Home
News | Ventricular Assist Devices (VAD)

A new study published in Circulation Research finds use of hemodynamic support with the Impella 2.5 heart pump during high-risk percutaneous coronary intervention (HRPCI) can reduce the risk of acute kidney injury (AKI) even when those patients had pre-existing kidney disease1 and low ejection fraction (EF). The new study builds upon earlier data from PROTECT II, a randomized clinical trial, which found kidney injury rates were numerically lower when more contrast was used during HRPCI, and adds to the growing body of evidence of the benefits of hemodynamic support with Impella during HRPCI, according to Abiomed.

Home March 09, 2017
Home
News | Peripheral Artery Disease (PAD)

Medtronic plc announced the launch of the IN.PACT BTK study to evaluate the effectiveness of a drug-coated balloon (DCB) in patients with below-the-knee (BTK) peripheral arterial disease (PAD). This study will evaluate the IN.PACT 0.014 paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter. This is an investigational device, which uses Medtronic’s IN.PACT Admiral drug coating technology.

Home March 09, 2017
Home
News | Heart Valve Technology

March 9, 2017 — Boston Scientific announced the German District Court of Düsseldorf has determined that Edwards ...

Home March 09, 2017
Home
News | Heart Failure

A Whitehall, Ohio man is the first in the United States to undergo a brand new treatment designed to remove excess fluid from hospitalized patients suffering from congestive heart failure, which affects six million Americans. The trial procedure occurred recently at The Ohio State University Richard M. Ross Heart Hospital.

Home March 08, 2017
Home
News | Computed Tomography (CT)

Through computed tomography (CT) images of the heart and other types of imaging, build-up of dangerous coronary plaques — which restrict the flow of blood to the heart — can be detected, even before a person develops symptoms of heart disease. Because of this, there is increasing interest in using these imaging techniques to screen for heart disease. According to a review published recently in JACC: Cardiovascular Imaging, a simple CT imaging technique called a coronary artery calcium (CAC) scan — often referred to as a calcium scan—may be particularly useful when screening for coronary artery disease.

Home March 08, 2017
Home
News | Ventricular Assist Devices (VAD)

Congestive heart failure patients at the University of Alabama at Birmingham (UAB) now have reason for optimism with a device that can improve quality of life while waiting for a heart transplant.

Home March 08, 2017
Home
News | Information Technology

Despite global political uncertainties and a sluggish economic outlook for 2017, the global healthcare industry is set for an invigorating year, according to a new analysis from Frost & Sullivan. This outlook is due to a partial realization of major healthcare policies and initiatives, technology advancements and value-based care driving the adoption and need for consumer-centric targeted therapies. Future drugs and medical devices will be more targeted to meet the unique needs of emerging markets (e.g. China, India, Brazil) which demonstrate high growth opportunities compared developed markets (e.g., the United States and Western Europe. Growing at a CAGR of 4.8 percent, the industry is likely to reach revenue of $1,731.8 billion.

Home March 08, 2017
Home
News | Cardiovascular Information Systems (CVIS)

March 7, 2017 — Lumedx Corp. announced recently it has been chosen by Adventist Health System to provide a ...

Home March 07, 2017
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

March 7, 2017 — Medtronic plc recently announced an economic analysis of five-year data showing that patients with mild ...

Home March 07, 2017
Home
Technology | Radiation Dose Management

March 7, 2017 — Unfors RaySafe recently introduced the RaySafe i3, to its suite of real-time dosimetry products, at the ...

Home March 07, 2017
Home
News | Congenital Heart

Philips and Phoenix Children’s Hospital (Arizona) announced a long-term strategic partnership with a total value of up to $65 million, providing the hospital access to Philips’ advanced medical technologies. Phoenix Children’s is the first stand-alone children’s health system to sign a long-term strategic partnership model with Philips.

Home March 07, 2017
Home
Subscribe Now